鉴定致病性Flaviviridae的无活性的NS2B-NS3蛋白酶的其他小分子结合点
Hovakim Grabski1,2, Siranuysh Grabska1,2, Ruben Abagyan1
1Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, La Jolla, San Diego, CA 92093-0657, USA.
Viruses
|January 25, 2025
概括
研究人员在NS2B-NS3蛋白酶上发现了新的全结合位,NS2B-NS3蛋白酶是开发新抗病毒药物治疗登革热等黄病毒病毒的关键目标. 这些地点为宽频抑制剂提供了潜在的潜力,克服了耐药性挑战.
科学领域:
- 病毒学和药物发现
- 结构生物学和生物信息学
背景情况:
- 流感病毒,包括登革热,西尼罗河病毒,寨卡病毒,黄热病和日本脑炎病毒,对全球健康构成重大风险.
- 开发有效的抗病毒疗法是具有挑战性的,因为病毒的快速突变和药物耐药性的出现.
- NS2B-NS3蛋白酶是flavivirus复制的关键酶,也是抗病毒干预的有希望的目标.
研究的目的:
- 识别和表征在多个黄病毒中NS2B-NS3蛋白酶上的新型全结位.
- 评估药用性和开发针对这些部位的小分子抑制剂的潜力.
- 评估制造多病毒抑制剂的可行性,这些抑制剂对各种亚型和耐药菌株有效.
主要方法:
- 在不同的非活性构造中对NS2B-NS3蛋白酶结构的计算分析.
- 对五种黄病毒和四种登革热病毒亚型的全囊的鉴定和特征.
- 评估口袋形状,药用性,病毒间相似性,序列变异和耐药性突变易感性.
主要成果:
- 在不活跃的蛋白酶状态中确定了两个有前途的全结合位点,与活跃位点不同.
- 这些口袋表现出针对特定的药物类小分子抑制剂的有利特征.
- 该研究分析了序列和结构变异,提供了对病毒特定向和多病毒抑制剂潜力的见解.
结论:
- 在NS2B-NS3蛋白酶上的新异位位代表了flavivirus感染的可行的治疗点.
- 这些网站提供了一个替代策略来克服现有的药物耐药性机制.
- 这些发现支持针对性小分子抑制剂的开发,可能导致广泛的抗病毒疗法.
相关概念视频
01:19Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
00:49Ligand Binding and Linkage
4.7K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.7K
01:08Allosteric Regulation
57.5K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
57.5K
02:34Enzymes
80.5K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
80.5K
01:58Cooperative Allosteric Transitions
7.8K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.8K
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.5K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.5K